Purchase
Description
Obinutuzumab biosimilar is a humanized anti-CD20 monoclonal antibody of the IgG1 subclass. It recognizes a specific epitope of the CD20 molecule found on B cells. The molecular mass of the antibody is approximately 150 kDa. it is produced by mammalian cell (CHO) suspension culture. It was engineered for reduced fucose content as compared to a typical IgG1 produced in CHO cells.
Obinutuzumab biosimilar is supplied at a concentration of 25 mg/mL as a sterile, clear, colorless to slightly brown, preservative-free liquid, which contains 20 mM L-histidine/L-histidine hydrochloride, 240 mM trehalose, 0.02% poloxamer 188. The pH is 6.0.
Properties
|
Name
|
Obinutuzumab biosimilar
|
|
CAS
NO.
|
949142-50-1
|
|
Type
|
Whole
antibody
|
|
Source
|
Humanized (from mouse)
|
|
Target
|
CD20
|
|
Clone
|
Monoclone
|
|
Molecular
Weight
|
150 kDa
|
|
Formula
|
C6512H10060N1712O2020S44
|
|
Antibody
Form
|
Purified immunoglobulin
|
|
Physical
Form
|
Solution
|
|
Grade
Standard
|
Medicine Grade
|
|
Storage
|
-70±15℃ for long-term
storage, 2-8℃ for short-term storage, away from light.
|
Supply Ability
20 kilogram per year, Minimum order quantity is 1 gram.
Price
Inquiry
Material Safety Data Sheet
If you need more information, please contact us.
Certificate Of Analysis
/en/UploadFile/file/201805/20180508154511791179.rar
Detail information about the product please refer the website below：
https://en.wikipedia.org/wiki/Obinutuzumab
|
